Clarus Ventures III GP, L.P.'s Net Worth

$231 Million

Who is Clarus Ventures III GP, L.P.?

Clarus Ventures III GP, L.P. has an estimated net worth of $231 Million. This is based on reported shares across multiple companies, which include Imago BioSciences, Inc., Talaris Therapeutics, Inc., Praxis Precision Medicines, Inc., ESSA Pharma Inc., GRAYBUG VISION, INC., Annexon, Inc., Gritstone Oncology, Inc., Entasis Therapeutics Holdings Inc., AVROBIO, Inc., and Forty Seven, Inc..

SEC CIK

Clarus Ventures III GP, L.P.'s CIK is 0001620148

Past Insider Trading and Trends

2021 was Clarus Ventures III GP, L.P.'s most active year for acquiring shares with 24 total transactions. Clarus Ventures III GP, L.P.'s most active month to acquire stocks was the month of April. 2021 was Clarus Ventures III GP, L.P.'s most active year for disposing of shares, totalling 17 transactions. Clarus Ventures III GP, L.P.'s most active month to dispose stocks was the month of April. 2018 saw Clarus Ventures III GP, L.P. paying a total of $15,000,920.00 for 10,897,869 shares, this is the most they've acquired in one year. In 2021 Clarus Ventures III GP, L.P. cashed out on 49,042,428 shares for a total of $0.00, their largest year based on trade value.